Cargando…
Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma (ESCC) is the most common pathological type of esophageal cancer in China. However, patient survival time after surgery remains unsatisfactory, especially in those who are pN+. This retrospective study determined the value of postoperative adjuvant therapy for pati...
Autores principales: | Li, Juan, Qiu, Rong, Hu, Yuanping, Wang, Yuxiang, Qi, Zhan, He, Ming, Li, Yuekao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847342/ https://www.ncbi.nlm.nih.gov/pubmed/33553432 http://dx.doi.org/10.1155/2021/8571438 |
Ejemplares similares
-
Correlates of Long-Term Survival of Patients with pN+ Esophageal Squamous Cell Carcinoma after Esophagectomy
por: He, Ming, et al.
Publicado: (2021) -
Survival risk prediction model for patients with pT(1–3) N(0)M(0) esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes
por: Qi, Zhan, et al.
Publicado: (2021) -
Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma
por: Guo, Xu-feng, et al.
Publicado: (2014) -
Clinical study on postoperative recurrence in patients with pN1 esophageal squamous cell carcinoma
por: Guo, Xufeng, et al.
Publicado: (2015) -
Association of survival with adjuvant radiotherapy for pN0 esophageal cancer
por: Gao, Huijiang, et al.
Publicado: (2023)